Our present findings clearly showed that the novel triterpenoid compounds from C. fistula controlled hyperglycemia through activation of IRS-1/Akt-mediated insulin signaling mechanisms and through regulation of carbohydrate metabolic enzymes in the skeletal muscle and liver. This evidence concerns the gene AKT1 and Hyperglycemia.